Traditional Chinese drug composition for treating carotid atherosclerosis plaque

An arteriosclerosis and composition technology, which is applied in the field of traditional Chinese medicine compositions for treating carotid atherosclerosis plaques, can solve the problems of unsatisfactory clinical effect, trauma, high price and the like, and achieves good patient compliance, convenient administration, Inexpensive effect

Inactive Publication Date: 2012-04-25
陈文实
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Non-TCM treatments include carotid endarterectomy, carotid stent angioplasty, and photochemical carotid angioplasty, but are difficult, expensive, an

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese drug composition for treating carotid atherosclerosis plaque
  • Traditional Chinese drug composition for treating carotid atherosclerosis plaque

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044]The traditional Chinese medicine composition for treating carotid atherosclerotic plaque, each dose includes the following raw materials in parts by weight: astragalus 30g, codonopsis 16g, angelica 12g, chuanxiong 10g, rehmannia 16g, salvia miltiorrhiza 12g, safflower 12g, peach kernel 20g, and kudzu root 12g.

[0045] Dosage: oral decoction, 200 ml each time, twice a day, one dose per day. 8 weeks is a course of treatment.

Embodiment 2

[0047] The traditional Chinese medicine composition for treating carotid atherosclerotic plaque, each dose includes the following raw materials in parts by weight: 60g of astragalus, 26g of codonopsis, 24g of angelica, 18g of chuanxiong, 20g of rehmannia, 25g of salvia miltiorrhiza, 18g of safflower, 50g of peach kernel, and 40g of kudzu root.

[0048] Dosage: oral decoction, 200 ml each time, twice a day, one dose per day. 8 weeks is a course of treatment.

Embodiment 3

[0050] The traditional Chinese medicine composition for treating carotid atherosclerotic plaque, each dose includes the following raw materials in parts by weight: astragalus 40g, codonopsis 12g, angelica 20g, chuanxiong 14g, rehmannia 30g, salvia miltiorrhiza 30g, safflower 16g, peach kernel 60g, and kudzu root 26g.

[0051] Dosage: oral decoction, 200 ml each time, twice a day, one dose per day. 8 weeks is a course of treatment.

[0052] In actual application, the traditional Chinese medicine composition can increase or decrease each component and parts by weight according to the disease condition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese drug composition for treating carotid atherosclerosis plaque. The traditional Chinese drug composition comprises the following raw materials, wherein the raw materials comprise, by weight, 30-60 parts of mongolian milkvetch root, 12-26 parts of dangshen, 12-24 parts of angelica, 10-18 parts of szechwan lovage rhizome, 16-30 parts of rehmannia dride rhizome, 12-30 parts of dan-shen root, 12-18 parts of safflower, 20-60 parts of peach seed and 12-40 parts of lobed kudzuvine root. The traditional Chinese drug composition has advantages of scientific and reasonable formula, definite therapeutic effect, easy taking, and definite anti-arteriosclerosis therapeutic effect. With the traditional Chinese drug composition, the atherosclerotic plaque can be effectively eliminated so as to reduce the incidence and the re-admission rate of cardio-cerebrovascular important events. All the components of the traditional Chinese drug composition are the pure traditional Chinese drugs, no significant adverse reaction is generated, the safety is high, and the patient compliance is good. Compared to other drugs for treating the atherosclerosis, the traditional Chinese drug composition of the present invention has the following advantages that: the price is low, the traditional Chinese drug composition is easy to widely use in the community hospitals and the primary hospitals, such that the economic burden of the patient family and the society can be reduced, and the practicality is provided in the drug economics field.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating carotid atherosclerotic plaque. Background technique [0002] Carotid atherosclerotic plaque is a part of systemic atherosclerosis (AS). Through the detection of modern medical imaging technology, the degree of carotid atherosclerosis can be observed more accurately, and it is regarded as a window to reflect systemic AS lesions. Carotid atherosclerosis often coexists with coronary arteries and cerebral arteries, and the degree of lesion is directly related to the occurrence of cerebrovascular diseases. Early reduction and reversal of carotid atherosclerotic plaque can reduce the incidence of stroke. [0003] Atherosclerosis is a complex disease process characterized by lipid accumulation in the arterial wall, and its initial process is mainly the adsorption, participation and activation of various types of cells. Endothelial cell dysfunction, blood lipids and monocytes e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/804A61P9/10
Inventor 陈文实李仁柱刘继松张翼杜娟
Owner 陈文实
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products